Search Results - "DEMOLS, A"

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial by Demols, A., Borbath, I., Van den Eynde, M., Houbiers, G., Peeters, M., Marechal, R., Delaunoit, T., Goemine, J.-C., Laurent, S., Holbrechts, S., Paesmans, M., Van Laethem, J.-L.

“…There is a high unmet clinical need for treatments of advanced/metastatic biliary tract cancers after progression on first-line chemotherapy. Regorafenib has…”
Get full text

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study by Maréchal, R., Vos, B., Polus, M., Delaunoit, T., Peeters, M., Demetter, P., Hendlisz, A., Demols, A., Franchimont, D., Verset, G., Van Houtte, P., Van de Stadt, J., Van Laethem, J.L.

“…Induction chemotherapy has been suggested to impact on preoperative chemoradiation efficacy in locally advanced rectal cancer (LARC). To evaluate in LARC…”
Get full text

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study by Demols, A, Peeters, M, Polus, M, Marechal, R, Gay, F, Monsaert, E, Hendlisz, A, Van Laethem, J L

“…Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to evaluate the activity and…”
Get full text

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology by Borbath, I., Ceratti, A., Verslype, C., Demols, A., Delaunoit, T., Laurent, S., Deleporte, A., Vergauwe, P., Van Maanen, A., Sempoux, C., Van Cutsem, E., Van Laethem, J.L.

“…Cholangiocarcinomas are uncommon tumours with a poor prognosis, that frequently present epidermal growth factor receptor overexpression. In a multi-centre…”
Get full text

Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors by Demols, A., Borbath, I., Van den Eynde, M., Houbiers, G., Peeters, M., Marechal, R., Delaunoit, T., Goeminne, J., Laurent, S., Holbrechts, S., Paesmans, M., Van Laethem, J.

Get full text

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) by Rao, S., Anandappa, G., Capdevila, J., Dahan, L., Evesque, L., Kim, S., Saunders, M.P., Gilbert, D.C., Jensen, L.H., Samalin, E., Spindler, K.-L., Tamberi, S., Demols, A., Guren, M.G., Arnold, D., Fakih, M., Kayyal, T., Cornfeld, M., Tian, C., Catlett, M., Smith, M., Spano, J.-P.

“…Locally advanced or metastatic squamous carcinoma of the anal canal (SCAC) has poor prognosis following platinum-based chemotherapy. Retifanlimab…”
Get full text

Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial) by Piessevaux, H., Demey, W., Bols, A., Janssens, J., Polus, M., Rezaei Kalantari, H., Laurent, S., Demols, A., Humblet, Y., Deboever, G., Kargar Samani, K., Ferrante, M., Monsaert, E., Rondou, T., van Laethem, J.-L., Tejpar, S.

Get full text

Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer by Maréchal, R, Demols, A, Gay, F, De Maertelaere, V, Arvanitaki, M, Hendlisz, A, Van Laethem, J L

“…Gemcitabine monotherapy is the cornerstone of the treatment of patients suffering from advanced pancreatic cancer (PC). For a few years, new chemotherapeutic…”
Get more information

PP098-SUN PREVALENCE OF STARVATION OR CACHEXIA AT EARLY DIAGNOSIS OF CANCER PATIENTS by Demols, A, Depoortere, F, Leseine, S, Vereecken, S, Marchand, M, Van Laethem, J.-L, Pepersack, T, De Breucker, S, Dewulf, I, Mekinda Ngono, Z.L, Ghanooni, R, Simon, P, Nouwynck, C, Roumeguere, T, Van Gossum, A

Get full text

Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I–II study by Laurent, S., Monsaert, E., Boterberg, T., Demols, A., Borbath, I., Polus, M., Hendlisz, A., de Hemptinne, B., Mahin, C., Scalliet, P., Van Laethem, J.-L., Peeters, M.

“…The prognosis of pancreaticobiliary tumors is poor. The aim was to assess the feasibility of radiotherapy (RT) and concomitant gemcitabine and oxaliplatin in…”
Get full text

How to identify older patients with cancer who should benefit from comprehensive geriatric assessment? by Luce, S, De Breucker, S, Van Gossum, Au, Demols, A, Mekinda, Z, Ena, G, Kentos, A, Roumeguère, T, Ghanooni, R, Nouwynck, C, Van Laethem, J-L, Sokolow, Y, Simon, P, Bailly, B, Vervaet, C, Marchand, M, Pepersack, T

“…Abstract Introduction Although many studies describe benefits from the comprehensive assessment of older patients, the lack of geriatricians combined with the…”
Get full text

A Mobile Oncogeriatric Team (MOT) in a Belgian academic hospital: What is the opinion of elderly cancer patients? by Luce, S, De Breucker, S, Van Gossum, A, Leseine, S, Demols, A, Mekinda, Z, Compte, N, Maerevoet, M, Martinez Chanza, N, Van Laethem, J.-L, Youri, S, Simon, P, Roumeguere, T, Ghanooni, R, Bailly, B, Vervaet, C, Pepersack, T

Get full text

How to identify older cancer patients who should benefit from comprehensive geriatric assessment? by Luce, S, De Breucker, S, Van Gossum, Au, Demols, A, Mekinda, Z, Ena, G, Maerevoet, M, Bailly, B, Roumeguère, T, Ghanooni, R, Nouwynck, C, Van Laethem, J.L, Sokolow, Y, Simon, P, Bron, D, Vervaet, C, Marchand, M, Pepersack, T

Get full text

743PExploratory analysis based on tumour location and early metabolic tumour response of REACHIN, a randomized double-blinded placebo-controlled phase II trial of regorafenib after failure of gemcitabine/platinum-based chemotherapy for advanced and metastatic biliary tract tumours by Demols, A, Borbath, I, Guillaume, L, Van Laethem, J L, Goldman, S, Lhommel, R

“…Abstract Background REACHIN trial met its primary endpoint of improving PFS in patients with biliary tract cancer (BTC) treated with regorafenib (R) as…”
Get full text

Exploratory analysis based on tumour location and early metabolic tumour response of REACHIN, a randomized double-blinded placebo-controlled phase II trial of regorafenib after failure of gemcitabine/platinum-based chemotherapy for advanced and metastatic biliary tract tumours by Demols, A., Borbath, I., Guillaume, L., Van Laethem, J.L., Goldman, S., Lhommel, R.

Get full text

743P - Exploratory analysis based on tumour location and early metabolic tumour response of REACHIN, a randomized double-blinded placebo-controlled phase II trial of regorafenib after failure of gemcitabine/platinum-based chemotherapy for advanced and metastatic biliary tract tumours by Demols, A., Borbath, I., Guillaume, L., Van Laethem, J.L., Goldman, S., Lhommel, R.

“…REACHIN trial met its primary endpoint of improving PFS in patients with biliary tract cancer (BTC) treated with regorafenib (R) as compared to placebo (P):…”
Get full text

Regorafenib in Locally Advanced and Metastatic Intrahepatic or Hilar Cholangiocarcinoma: a Randomized Double-Blinded Phase Ii Trial. Reach In by Demols, A., Marechal, R., van Laethem, J.

Get full text

749TiPREGORAFENIB IN LOCALLY ADVANCED AND METASTATIC INTRAHEPATIC OR HILAR CHOLANGIOCARCINOMA: A RANDOMIZED DOUBLE-BLINDED PHASE II TRIAL. REACH IN by Demols, A., Marechal, R., van Laethem, J.

“…Abstract Background: There is no standard of care for advanced cholangiocarcinoma (CCK) after failure of gemcitabine and platinum-based chemotherapy…”
Get full text

Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II study by Van Laethem, J-L, Van Maele, Ph, Verslype, C, Polus, M, Demols, A, Houbiers, Gh, Caenepeel, P, Leleux, A, Vermaut, R R, Van Cutsem, E, Peeters, M

“…This multicenter phase II study was designed to determine the activity and tolerance of gemcitabine and raltitrexed in advanced pancreatic adenocarcinoma…”
Get more information

O-003Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors by Demols, A, Borbath, I, den Eynde, M Van, Houbiers, G, Peeters, M, Marechal, R, Delaunoit, T, Goeminne, J, Laurent, S, Holbrechts, S, Paesmans, M, Laethem, J Van

Get full text